Atlas Trials

Study of a New Intravenous Drug, Called S65487, in Patients With Acute Myeloid Leukemia, Non Hodgkin Lymphoma, Multiple Myeloma or Chronic Lymphocytic Leukemia

Clinical trial NCT03755154 · TERMINATED

Trial details

NCT number
NCT03755154
Sponsor
Institut de Recherches Internationales Servier
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Relapsed or Refractory Acute Myeloid LeukemiaRelapsed or Refractory Non-Hodgkin LymphomaRelapsed or Refractory Multiple MyelomaRelapsed or Refractory Chronic Lymphocytic Leukemia
Start date
2019-07-17
Primary completion
2023-11-06
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.